{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T18:34:19Z","timestamp":1770402859103,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2016,1,15]]},"DOI":"10.5664\/jcsm.5400","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T22:57:08Z","timestamp":1452812228000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study"],"prefix":"10.1007","volume":"12","author":[{"given":"Mansoor","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozina","family":"Aamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Jishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin B.","family":"Scharf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"1201012_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","volume":"38","author":"F Wolfe","year":"1995","unstructured":"Wolfe F, Ross K, Anderson J, Russel IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19\u201328.","journal-title":"Arthritis Rheum"},{"key":"1201012_CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0304-3959(96)03226-5","volume":"68","author":"G Affleck","year":"1996","unstructured":"Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 1996;68:363\u20138.","journal-title":"Pain"},{"key":"1201012_CR3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00006199-200305000-00002","volume":"52","author":"CA Landis","year":"2003","unstructured":"Landis CA, Frey CA, Lentz MJ, Rethernel J, Buchwald D, Shaver JLF. Self reported sleep quality and fatigue correlates with actigraphy sleep indicators in midlife women with fibromyalgia. Nurs Res 2003;52:140\u20137.","journal-title":"Nurs Res"},{"key":"1201012_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00006842-197601000-00006","volume":"38","author":"H Moldofsky","year":"1976","unstructured":"Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38:35\u201344.","journal-title":"Psychosom Med"},{"key":"1201012_CR5","first-page":"1586","volume":"26","author":"MJ Lentz","year":"1999","unstructured":"Lentz MJ, Landis CA, Rothermel J, Shaver JL. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol 1999;26:1586\u201392.","journal-title":"J Rheumatol"},{"key":"1201012_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/sleep\/29.2.145","volume":"29","author":"T Roehrs","year":"2006","unstructured":"Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T. Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006;29:145\u201351.","journal-title":"Sleep"},{"key":"1201012_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00006842-197507000-00008","volume":"37","author":"H Moldofsky","year":"1975","unstructured":"Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in subjects with \u2018fibrositis syndrome\u2019 and healthy controls. Psychosom Med 1975;37:341\u201351.","journal-title":"Psychosom Med"},{"key":"1201012_CR8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pec.2008.06.005","volume":"73","author":"LM Arnold","year":"2008","unstructured":"Arnold LM, Crofford LJ, Mease PJ, et al. Subject perspectives on the impact of fibromyalgia. Subject Educ Couns 2008;73:114\u201320.","journal-title":"Subject Educ Couns"},{"key":"1201012_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0889-857X(21)00037-5","volume":"15","author":"MB Yunus","year":"1989","unstructured":"Yunus MB, Kaylan-Roman UP. Muscle biopsy findings and primary fibromyalgia and other forms of non articular rheumatism. Rheum Dis Clin North Am 1989;15:115\u201334.","journal-title":"Rheum Dis Clin North Am"},{"key":"1201012_CR10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1201012_CR11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.sleep.2007.10.022","volume":"9","author":"JW Burns","year":"2008","unstructured":"Burns JW, Crofford LJ, Chervin RD. Sleep stage dynamics in fibromyalgia subjects and controls. Sleep Med 2008;9:689\u201396.","journal-title":"Sleep Med"},{"key":"1201012_CR12","first-page":"367","volume":"315","author":"SM Harding","year":"1998","unstructured":"Harding SM. Sleep in fibromyalgia subjects: subjective and objective findings. Am J Med Sci 1998;315:367\u201376.","journal-title":"Am J Med Sci"},{"key":"1201012_CR13","first-page":"541","volume":"41","author":"S Jacobsen","year":"1994","unstructured":"Jacobsen S. Chronic widespread musculoskeletal pain\u2014the fibromyalgia syndrome.[Thesis]. Dan Med Bull 1994;41:541\u201364.","journal-title":"Dan Med Bull"},{"key":"1201012_CR14","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3899\/jrheum.090051","volume":"36:9","author":"R Chervin","year":"2009","unstructured":"Chervin R, et al. Objective measures of disordered sleep in fibromyalgia. J Rheumatology 2009;36:9:2009\u201316.","journal-title":"J Rheumatology"},{"key":"1201012_CR15","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.clinthera.2008.11.009","volume":"30","author":"DJ Clauw","year":"2008","unstructured":"Clauw DJ, Mease P, Palmer RH, Gendreau M, Wang Y. Milnaciprin for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multi-dose clinical trial. Clin Ther 2008;30:1988\u20132004.","journal-title":"Clin Ther"},{"key":"1201012_CR16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3899\/jrheum.080734","volume":"36","author":"PJ Mease","year":"2009","unstructured":"Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:398\u2013409.","journal-title":"J Rheumatol"},{"key":"1201012_CR17","first-page":"1975","volume":"32","author":"RM Gendreau","year":"2005","unstructured":"Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in subjects with fibromyalgia. J Rheumatol 2005;32:1975\u201385.","journal-title":"J Rheumatol"},{"key":"1201012_CR18","first-page":"S603","volume":"56","author":"D Goldenberg","year":"2007","unstructured":"Goldenberg D, Clauw DJ, Palmer R, Mease P, Gendreau RM. One-year durability of response to milnacipran treatment for fibromyalgia. Arthritis Rheum 2007;56:S603.","journal-title":"Arthritis Rheum"},{"key":"1201012_CR19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pain.2010.02.043","volume":"149","author":"ME Geisser","year":"2010","unstructured":"Geisser ME, Clauw DJ, Strand V, Gendreau RM, Palmer R, Williams DA. Contributions of change in clinical status parameters to Subject Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Pain 2010;149:373\u20138.","journal-title":"Pain"},{"key":"1201012_CR20","volume-title":"A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects","author":"A Rechtschaffen","year":"1968","unstructured":"Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. NIH Publication. No 204. Washington, DC: US Government Printing Office, 1968."},{"key":"1201012_CR21","volume-title":"The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications","author":"C Iber","year":"2007","unstructured":"Iber C, Ancoli-Israel S, Chesson AL Jr, Quan SF. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester, IL: American Academy of Sleep Medicine, 2007."},{"key":"1201012_CR22","volume-title":"MOS Sleep Scale: a manual for use and scoring, Version 1.0","author":"KL Spritzer","year":"2003","unstructured":"Spritzer KL, Hays RD. MOS Sleep Scale: a manual for use and scoring, Version 1.0. Los Angeles, CA, 2003."},{"key":"1201012_CR23","first-page":"728","volume":"18","author":"CS Burckhardt","year":"1991","unstructured":"Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18:728\u201334.","journal-title":"J Rheumatol"},{"key":"1201012_CR24","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129\u201338.","journal-title":"Ann Acad Med Singapore"},{"key":"1201012_CR25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0022-3999(93)90104-N","volume":"37","author":"JE Schwartz","year":"1993","unstructured":"Schwartz JE, Jandorf L, Krupp LB. The measurement of fatigue: a new instrument. J Psychosom Res 1993;37:753\u201362.","journal-title":"J Psychosom Res"},{"key":"1201012_CR26","first-page":"1","volume-title":"Beck Depression Inventory-Second Edition manual","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK. Beck Depression Inventory-Second Edition manual. San Antonio, TX, The Psychological Corporation, 1996:1\u201338."},{"key":"1201012_CR27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmpt.2003.11.003","volume":"27","author":"H Hurst","year":"2004","unstructured":"Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther 2004;27:26\u201335.","journal-title":"J Manipulative Physiol Ther"},{"key":"1201012_CR28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2146\/ajhp100322","volume":"68","author":"LM Traynor","year":"2011","unstructured":"Traynor LM, Thiessen CN, Traynor AP. Pharmacotherapy of fibromyalgia. Am J Health Syst Pharm 2011;68:1307\u201319.","journal-title":"Am J Health Syst Pharm"},{"key":"1201012_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hup.622","volume":"19","author":"O Vitton","year":"2004","unstructured":"Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004;19:27\u201335.","journal-title":"Hum Psychopharmacol"},{"key":"1201012_CR30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hup.600","volume":"19","author":"P Lemoine","year":"2004","unstructured":"Lemoine P, Faivre T. Subjective and polysomnographic effects of milnacipran on sleep in depressed subjects. Hum Psychopharmacol Clin Exp 2004;19:299\u2013303.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"1201012_CR31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2869.2008.00638.x","volume":"17","author":"JF Van Den Berg","year":"2008","unstructured":"Van Den Berg JF, Van Rooij FJ, Vos H, et al. Disagreement between subjective and actigraphic measures of sleep duration in a population-based study of elderly persons. J Sleep Res 2008;17:295\u2013302.","journal-title":"J Sleep Res"},{"key":"1201012_CR32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jsr.12220","volume":"24","author":"DB Kay","year":"2015","unstructured":"Kay DB, Buysse DJ, Germain A, Hall M, Monk TH. Subjective-objective sleep discrepancy among older adults: associations with insomnia diagnosis and insomnia treatment. J Sleep Res 2015;24:32\u20139.","journal-title":"J Sleep Res"},{"key":"1201012_CR33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2125.2000.00124.x","volume":"49","author":"l Hindmarch","year":"2000","unstructured":"Hindmarch l, Rigney U, Stanley N, Briley M. Pharmacodynamics of milnacipran in young and elderly volunteers. Br J Clin Pharamacol 2000;49:118\u201325.","journal-title":"Br J Clin Pharamacol"},{"key":"1201012_CR34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopsych.2003.07.006","volume":"55","author":"SN Vaikshnavi","year":"2004","unstructured":"Vaikshnavi SN, Nemeroff CB, Plott SJ, Rao SG, Kranzler J, Owens MJ. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry 2004;55:320\u20132.","journal-title":"Biol Psychiatry"},{"key":"1201012_CR35","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/syn.20893","volume":"7","author":"M Rahmadi","year":"2011","unstructured":"Rahmadi M, Narita M, Yamashita A, Imai S, Kuzumaki N, Suzuki T. Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milacipran. Synapse 2011;7:652\u20137.","journal-title":"Synapse"},{"key":"1201012_CR36","first-page":"2263","volume":"4","author":"HW Agnew","year":"1996","unstructured":"Agnew HW, Wess WB, Williams RL. The first night effects: an EEG study of sleep. Psychophysiology 1996;4:2263\u20136.","journal-title":"Psychophysiology"},{"key":"1201012_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-8986.1975.tb00013.x","volume":"12","author":"MB Scharf","year":"1975","unstructured":"Scharf MB, Bixler EO, Kales A. Readaptation to the sleep laboratory in insomnia subjects. Psychophysiology 1975;12:69\u201373.","journal-title":"Psychophysiology"},{"key":"1201012_CR38","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3899\/jrheum.101025","volume":"38","author":"JC Branco","year":"2011","unstructured":"Branco JC, Cherin P, Montagne A, Bouroubi A. Multinational Coordinator Study Group Long term therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study. J Rheumatol 2011;38:1403\u201312.","journal-title":"J Rheumatol"},{"key":"1201012_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hup.622","volume":"19","author":"O Vitton","year":"2004","unstructured":"Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004;19:27\u201335.","journal-title":"Hum Psychopharmacol"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.5400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.5400\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.aasmnet.org\/jcsm\/viewabstract.aspx?pid=30422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.5400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:15:25Z","timestamp":1770365725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.5664\/jcsm.5400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1,15]]}},"alternative-id":["1201012"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.5400","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,15]]},"assertion":[{"value":"1 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}